Elevation Oncology, Inc. (ELEV)
Data as of , from SEC Form 4 filings.
See up to 3 months of ELEV. The 7-day demo opens the 1M and 3M ranges and puts ELEV on your watchlist.
Start 7-day demoLatest ELEV insider trades
About Elevation Oncology, Inc. (ELEV)
Elevation Oncology, Inc. files with the SEC under CIK 0001783032 and is classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
ELEV Form 4 activity by transaction type, last 90 days
No Form 4 activity for ELEV in the last 90 days.
ELEV insider transactions (Form 4)
4111 Form 4 filings on record, the earliest from Nov 19, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Darcy Mootz | Derivative | Stock Option (Right to Buy) | 55,000 | $0.00 | - | |
| Darcy Mootz | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Darcy Mootz | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Alan B. Sandler | Derivative | Stock Option (Right to Buy) | 55,000 | $0.00 | - | |
| Alan B. Sandler | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Alan B. Sandler | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Tammy Furlong - Officer | Other | Common Stock | 37,957 | $0.36 | $14K | |
| Tammy Furlong - Officer | Derivative | Stock Option (Right to Buy) | 79,327 | $0.00 | - | |
| Tammy Furlong - Officer | Derivative | Stock Option (Right to Buy) | 79,327 | $0.00 | - | |
| Tammy Furlong - Officer | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Tammy Furlong - Officer | Derivative | Stock Option (Right to Buy) | 52,500 | $0.00 | - | |
| Tammy Furlong - Officer | Derivative | Stock Option (Right to Buy) | 28,800 | $0.00 | - | |
| Tammy Furlong - Officer | Derivative | Stock Option (Right to Buy) | 53,433 | $0.00 | - | |
| Tammy Furlong - Officer | Derivative | Stock Option (Right to Buy) | 225,000 | $0.00 | - | |
| Tammy Furlong - Officer | Derivative | Stock Option (Right to Buy) | 275,000 | $0.00 | - | |
| Julie M. Cherrington | Derivative | Stock Option (Right to Buy) | 55,000 | $0.00 | - | |
| Julie M. Cherrington | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Julie M. Cherrington | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| R. Michael Carruthers | Derivative | Stock Option (Right to Buy) | 47,330 | $0.00 | - | |
| R. Michael Carruthers | Derivative | Stock Option (Right to Buy) | 15,619 | $0.00 | - | |
| R. Michael Carruthers | Derivative | Stock Option (Right to Buy) | 31,238 | $0.00 | - | |
| R. Michael Carruthers | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| R. Michael Carruthers | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Steve Elms | Derivative | Stock Option (Right to Buy) | 31,238 | $0.00 | - | |
| Steve Elms | Derivative | Stock Option (Right to Buy) | 15,619 | $0.00 | - | |
| Steve Elms | Derivative | Stock Option (Right to Buy) | 31,238 | $0.00 | - | |
| Steve Elms | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Steve Elms | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Timothy P. Clackson | Other | Common Stock | 47,330 | $0.36 | $17K | |
| Timothy P. Clackson | Derivative | Stock Option (Right to Buy) | 15,619 | $0.00 | - | |
| Timothy P. Clackson | Derivative | Stock Option (Right to Buy) | 31,238 | $0.00 | - | |
| Timothy P. Clackson | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Timothy P. Clackson | Derivative | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Steve Elms | Grant or award | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Timothy P. Clackson | Grant or award | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Joseph J. Ferra Jr. - Officer | Option exercise | Common Stock | 12,563 | - | - | |
| Joseph J. Ferra Jr. - Officer | Tax withholding / forfeiture | Common Stock | 4,629 | $0.64 | $3K | |
| Joseph J. Ferra Jr. - Officer | Option exercise | Restricted Stock Unit | 12,563 | $0.00 | - | |
| Tammy Furlong - Officer | Option exercise | Common Stock | 300 | - | - | |
| Tammy Furlong - Officer | Tax withholding / forfeiture | Common Stock | 98 | $0.53 | $52 | |
| Tammy Furlong - Officer | Option exercise | Restricted Stock Unit | 300 | $0.00 | - |
ELEV insider trading FAQ
What is the latest insider trade for ELEV?
Elevation Oncology, Inc. (ELEV) has filed no insider reports in the last 90 days. The most recent on record is dated 23 July 2025. The full record for ELEV runs to 11 Form 4 filings, the earliest from 19 November 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ELEV stock?
No insider purchases of ELEV were filed in the last 90 days.
How many insiders are selling ELEV stock?
No insider sales of ELEV were filed in the last 90 days.
Where can I see ELEV SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ELEV Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Darcy Mootz view on EDGAR
- - Alan B. Sandler view on EDGAR
- - Tammy Furlong view on EDGAR
- - Julie M. Cherrington view on EDGAR
- - R. Michael Carruthers view on EDGAR
- - Steve Elms view on EDGAR
- - Timothy P. Clackson view on EDGAR
- - Steve Elms view on EDGAR
- - Timothy P. Clackson view on EDGAR
- - Joseph J. Ferra Jr. view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ELEV's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ELEV with a 7-day demo
- ELEV on your watchlist
- Every ELEV Form 4 filing on record
- Up to 3 months of ELEV price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
